About VitVio
VitVio is a company based in San Francisco (United States) founded in 2023 by Thomas Knox, Aleks Pajewski, and Maks Kozarzewski. VitVio has raised $10 million across 2 funding rounds from investors including Tiny VC, LDV Capital and Bek Ventures. VitVio offers products and services including AI Surgical Tool Tracking, Surgery Runway, and Tailored Learning. VitVio operates in a competitive market with competitors including Caresyntax, ClearPoint Neuro, Cydar Medical, Perfint Healthcare and MediView, among others.
- Headquarter San Francisco, United States
- Founders Thomas Knox, Aleks Pajewski, Maks Kozarzewski
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vitvio Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Seed
Oct 23, 2025
-
Investors
Tiny VC
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VitVio
VitVio offers a comprehensive portfolio of products and services, including AI Surgical Tool Tracking, Surgery Runway, and Tailored Learning.
Tracks surgical tools to reduce waste and costs in operating rooms.
Provides real-time estimates for surgery progress and triggers actions.
Offers training based on real hospital surgeries for better staff preparation.
People of VitVio
Unlock access to complete
Unlock access to complete
Funding Insights of VitVio
VitVio has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $8 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VitVio
VitVio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Tiny VC, LDV Capital and Bek Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused VC firm
|
Locked | Locked | Locked | |
|
Bek Ventures is focused on supporting early-stage founders.
|
Locked | Locked | Locked | |
|
Early-stage investments are provided in frontier tech by Balnord.
|
Locked | Locked | Locked |
Investor details for VitVio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VitVio
Investment portfolio details for VitVio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VitVio
Detailed financials for VitVio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vitvio Comparisons
Peer comparison for VitVio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VitVio
VitVio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caresyntax, ClearPoint Neuro, Cydar Medical, Perfint Healthcare and MediView, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical outcomes are enhanced via analytics and integration platform.
|
|
| Locked | Locked | Locked |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| Locked | Locked | Locked |
Surgical images are analyzed via AI for endovascular procedures.
|
|
| Locked | Locked | Locked |
Solutions for image-guided interventional procedures are developed.
|
|
| Locked | Locked | Locked |
Digital medical images are managed for healthcare providers.
|
|
| Locked | Locked | Locked |
Surgical systems using AI sensors are developed for operating rooms.
|
Detailed competitors of VitVio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vitvio
Complete news archive for VitVio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VitVio
VitVio was founded in 2023 and raised its 1st funding round 1 year after it was founded.
VitVio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Thomas Knox is the current CEO of VitVio. They have also founded this company.
VitVio is a funded company, having raised a total of $10M across 2 funding rounds to date.
AI and computer vision platform for surgical operating rooms. The platform track and analyze surgical procedures, tool usage, and adherence to protocols in real time enhance the number of surgeries performed per day, eliminate delays, enhance communication actionability, and reduce the likelihood of readmissions.
VitVio's top competitors include Caresyntax, ClearPoint Neuro and VISIE.
VitVio offers AI Surgical Tool Tracking, Surgery Runway, and Tailored Learning.
VitVio has 4 investors. Key investors include Tiny VC, LDV Capital, Bek Ventures, and Balnord.